Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

225 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ovarian cancer development and metastasis.
Lengyel E. Lengyel E. Am J Pathol. 2010 Sep;177(3):1053-64. doi: 10.2353/ajpath.2010.100105. Epub 2010 Jul 22. Am J Pathol. 2010. PMID: 20651229 Free PMC article.
The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinoma.
Bishop EA, Lengyel ER, Yamada SD, Montag A, Temkin SM. Bishop EA, et al. Gynecol Oncol. 2011 Apr;121(1):218-23. doi: 10.1016/j.ygyno.2010.11.031. Epub 2010 Dec 17. Gynecol Oncol. 2011. PMID: 21168200
Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
Lengyel E, Schmalfeldt B, Konik E, Späthe K, Härting K, Fenn A, Berger U, Fridman R, Schmitt M, Prechtel D, Kuhn W. Lengyel E, et al. Gynecol Oncol. 2001 Aug;82(2):291-8. doi: 10.1006/gyno.2001.6243. Gynecol Oncol. 2001. PMID: 11531282
Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis.
Mitra AK, Chiang CY, Tiwari P, Tomar S, Watters KM, Peter ME, Lengyel E. Mitra AK, et al. Among authors: lengyel e. Oncogene. 2015 Nov 26;34(48):5923-32. doi: 10.1038/onc.2015.43. Epub 2015 Mar 23. Oncogene. 2015. PMID: 25798837 Free PMC article.
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
Schmalfeldt B, Prechtel D, Härting K, Späthe K, Rutke S, Konik E, Fridman R, Berger U, Schmitt M, Kuhn W, Lengyel E. Schmalfeldt B, et al. Among authors: lengyel e. Clin Cancer Res. 2001 Aug;7(8):2396-404. Clin Cancer Res. 2001. PMID: 11489818
Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer.
Schaller G, Fuchs I, Pritze W, Ebert A, Herbst H, Pantel K, Weitzel H, Lengyel E. Schaller G, et al. Among authors: lengyel e. Clin Cancer Res. 1996 Nov;2(11):1879-85. Clin Cancer Res. 1996. PMID: 9816144
Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis.
Mitra AK, Sawada K, Tiwari P, Mui K, Gwin K, Lengyel E. Mitra AK, et al. Among authors: lengyel e. Oncogene. 2011 Mar 31;30(13):1566-76. doi: 10.1038/onc.2010.532. Epub 2010 Nov 29. Oncogene. 2011. PMID: 21119598 Free PMC article.
MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment.
Kohlhapp FJ, Mitra AK, Lengyel E, Peter ME. Kohlhapp FJ, et al. Among authors: lengyel e. Oncogene. 2015 Nov 26;34(48):5857-68. doi: 10.1038/onc.2015.89. Epub 2015 Apr 13. Oncogene. 2015. PMID: 25867073 Free PMC article. Review.
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer.
King ML, Lindberg ME, Stodden GR, Okuda H, Ebers SD, Johnson A, Montag A, Lengyel E, MacLean Ii JA, Hayashi K. King ML, et al. Among authors: lengyel e. Oncogene. 2015 Jun;34(26):3452-62. doi: 10.1038/onc.2014.277. Epub 2014 Sep 1. Oncogene. 2015. PMID: 25174399 Free PMC article.
Epithelial ovarian cancer experimental models.
Lengyel E, Burdette JE, Kenny HA, Matei D, Pilrose J, Haluska P, Nephew KP, Hales DB, Stack MS. Lengyel E, et al. Oncogene. 2014 Jul 10;33(28):3619-33. doi: 10.1038/onc.2013.321. Epub 2013 Aug 12. Oncogene. 2014. PMID: 23934194 Free PMC article. Review.
225 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page